ELP2 negatively regulates osteoblastic differentiation impaired by tumor necrosis factor α in MC3T3-E1 cells through...

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• Tumor necrosis factor-α (TNF-α) is a key inflammatory mediator impacting bone metabolism.
• Chronic inflammation can lead to bone dysplasia by disrupting osteogenic differentiation.
• Signal transducer and activator of transcription 3 (STAT3)-interacting protein 1 (StIP1), also known as elongator complex protein 2 (ELP2), is implicated in inhibiting TNF-α-induced osteoblast differentiation.

Purpose of the Study:

• To investigate the role and mechanism of ELP2 activation in mediating TNF-α's effects on osteoblastic differentiation.
• To elucidate the signaling pathways involved in ELP2-mediated inhibition of osteogenesis.

Main Methods:

• In vitro cell culture of preosteoblastic MC3T3-E1 cells.
• Manipulation of ELP2 expression (forced expression and silencing).
• Assessment of osteoblast marker gene expression, alkaline phosphatase activity, and matrix mineralization.

Main Results:

• TNF-α inhibited osteoblastic differentiation, increasing ELP2 expression and STAT3 activation in MC3T3-E1 cells.
• Forced ELP2 expression suppressed osteogenic differentiation markers and mineralization.
• ELP2 silencing rescued osteogenic differentiation despite TNF-α stimulation, implicating ELP2 in TNF-α's inhibitory action.
• ELP2 upregulation and subsequent inhibition of osteogenesis were linked to Janus kinase 2 (JAK2)/STAT3 activation.

Conclusions:

• ELP2 is upregulated during osteoblast differentiation in response to TNF-α.
• ELP2 activation mediates TNF-α's inhibitory effect on osteogenic differentiation.
• The JAK2/STAT3 signaling pathway is crucial for ELP2-mediated inhibition of osteoblast differentiation.